Today is your day to innovate
In 1989, Peter Farrell founded ResMed to treat obstructive sleep apnea in innovative new ways. In one day, that single idea would change the lives of millions of people around the world. Today, we’re a team of more than 4,000 employees, thinking, creating and challenging ourselves to better serve our patients – every day.
To this day, we continue to be energized by Peter and his entrepreneurial spirit as we move forward toward the future. His foundation of innovation continues to inspire and empower us as we:
- Advance education, awareness and screening around sleep apnea and respiratory conditions
- Create better diagnosis and therapy solutions for patients
- Enhance respiratory care and management for healthcare professionals
At ResMed, every team member at every level of the organization can do extraordinary work and deliver innovation. It’s through this confidence in our people that we’ve developed and delivered a broad range of innovative products and solutions.
Headquartered in San Diego, CA, we have research and development, manufacturing, sales and support offices in more than 100 countries across the globe, including Brazil, China, Egypt, France, Germany, Japan, Portugal, South Africa, Australia and the United Kingdom. Join us, and you become part of the team that’s led the medical device industry for more than 25 years, with more than 3,000 patents issued and pending, and more than $1.5 billion in annual revenue.
Awards / Recognition
At ResMed, we are constantly thinking beyond the horizon and challenging ourselves to remain visionaries of the industry we created. We’ve always done things our own way. With integrity. With passion. And with the aspiration to improve lives with our expertise. We’re honored to be recognized with these distinctions:
- World’s Top 50 Companies — Citigroup
- Two Innovation Excellence Awards — Red Dot Design Awards, 2014
- 2014 Healthiest Company (medium-size employer) — San Diego Business Journal
In 1981, Professor Colin Sullivan of the University of Sydney created the first continuous positive airway pressure (CPAP) device. Built from a reverse vacuum cleaner pump, the device was the first noninvasive treatment for obstructive sleep apnea. While many saw its potential, only Dr. Peter Farrell recognized a commercial opportunity. In 1989, he founded ResMed to advance the treatment of sleep apnea, and in 1995, we began trading on NASDAQ. In 1999, we transferred our principal public listing to the NYSE. In late 1999, we established a secondary listing of our common stock on the Australian Stock Exchange.
As awareness of sleep apnea increases, ResMed continues to grow. Our innovative solutions have defined superior performance and comfort across the industry. And the numbers speak for themselves: the company generated revenue of US $1.6 billion in FY 2014 and had a five-year annual growth rate of 11 percent in revenue and 19 percent in net income.”
We believe that the passion and commitment of our team is responsible for our success. So as we continue to grow and work together, we look forward to a successful future for our company and our team members.